CDKN1A and gallbladder cancer: STMN1 silencing resulted in inhibited cell growth, induced apoptosis and delayed G2/M phase transition in gallbladder cancer cells by regulating the activity of p38 MAPK kinase and p53/p21 signal pathways [81].